Who owns Skye Bioscience, Inc.?
- Ticker: SKYE
- CUSIP Number: 83086j200
Tip: Access positions for across all investors
Analyze quarterly positions in Skye Bioscience with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Skye Bioscience stock
Who bought or sold Skye Bioscience, Inc. this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| 5AM Venture Management | 9.7M | $6.7M | 0% | Jun 2026 |
|
| Versant Venture Management | 2.0M | $1.4M | 0% | Jun 2026 |
|
| Baker Bros. Advisors | 1.6M | $1.1M | 0% | Jun 2026 |
|
| Vanguard Capital Management | 764k | $529k | 0% | Jun 2026 |
|
| Sphera Funds Management | 679k | $471k | 0% | Jun 2026 |
|
| Platinum Investment Mangement | 233k | $162k | 0% | Jun 2026 |
|
| BlackRock | 233k | $162k | -19% | Jun 2026 |
|
| Geode Capital Management | 218k | $151k | -21% | Jun 2026 |
|
| Millennium Management | 199k | $138k | -23% | Jun 2026 |
|
| Citadel Advisors | 124k | $86k | 25% | Jun 2026 |
|
| Vanguard Fiduciary Trust | 104k | $72k | 0% | Jun 2026 |
|
| State Street Corporation | 75k | $46k | 0% | Mar 2026 |
|
| UBS Group | 74k | $51k | 61% | Jun 2026 |
|
| Northern Trust | 56k | $39k | 180% | Jun 2026 |
|
| Qube Research & Technologies | 43k | $30k | 100% | Jun 2026 |
|
| Simplex Trading | 27k | $19k | 100% | Jun 2026 |
|
| XTX Topco | 21k | $15k | -49% | Jun 2026 |
|
| Engineers Gate Manager | 20k | $14k | 0% | Jun 2026 |
|
| Group One Trading | 4.6k | $3.2k | -36% | Jun 2026 |
|
| Vanguard Global Advisers | 4.6k | $3.2k | 0% | Jun 2026 |
|
| Mercer Global Advisors | 3.1k | $2.1k | 100% | Jun 2026 |
|
| Morgan Stanley | 2.5k | $1.6k | -40% | Mar 2026 |
|
| Barclays | 655.00 | $455.028500 | -96% | Jun 2026 |
|
| Advisor Group Holdings | 600.00 | $412.980000 | 0% | Jun 2026 |
|
| National Bank Of Canada /fi/ | 400.00 | $275.000000 | 0% | Jun 2026 |
|
| Royal Bank of Canada | 120.00 | $0 | -6% | Jun 2026 |
|
| Jpmorgan Chase & Co | 66.00 | $44.002200 | 100% | Jun 2026 |
|
| Zurcher Kantonalbank | 52.00 | $35.999600 | 0% | Jun 2026 |
|
| TD Waterhouse Canada | 52.00 | $35.001200 | -34% | Jun 2026 |
|
| Federation des caisses Desjardins du Quebec | 51.00 | $35.001300 | 0% | Jun 2026 |
|
| Rockefeller Capital Management | 39.00 | $26.999700 | 0% | Jun 2026 |
|
| Optiver Holding B.V. | 20.00 | $14.000000 | 0% | Jun 2026 |
|
| CoreCap Advisors | 8.00 | $6.000000 | 0% | Jun 2026 |
|
| Jones Financial Companies, L.L | 8.00 | $5.000000 | 100% | Jun 2026 |
|
| Gilpin Wealth Management | 4.00 | $3.000000 | 100% | Jun 2026 |
|
| Plante Moran Financial Advisors | 3.00 | $2.000100 | 0% | Jun 2026 |
|
| Mcguire Capital Advisors | 2.00 | $1.000000 | 0% | Jun 2026 |
|
| Citigroup | 2.00 | $1.000000 | 100% | Mar 2026 |
|
| Wells Fargo & Company | 1.00 | $1.000000 | 100% | Jun 2026 |
|
| FMR | 1.00 | $1.000000 | 100% | Jun 2026 |
|
| IFP Advisors | 1.00 | $1.000000 | -50% | Jun 2026 |
|
| Harbour Investments | 1.00 | $1.000000 | 0% | Jun 2026 |
|
| Newbridge Financial Services Group | 1.00 | $1.000000 | 0% | Jun 2026 |
|
| Leo H. Evart | 1.00 | $1.000000 | 0% | Jun 2026 |
|
| PFS Partners | 1.00 | $1.000000 | 0% | Jun 2026 |
|
Who sold out of Skye Bioscience?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Two Sigma Investments | Mar 2026 | 26k | $16k |
| Federated Investors | Mar 2026 | 1.2k | $712.054200 |